Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Orlando Piro"'
Autor:
Giulio Bonzani, Clelia Esposito, Luigi Ascione, Paola Elvira Mocavero, Ida Monteforte, Antonio Corcione, Pio Caso, Orlando Piro, Emanuele Cigala, Mario Crisci, Vittorio Monda, Enrico Melillo
Publikováno v:
Seminars in cardiothoracic and vascular anesthesia. 23(4)
Percutaneous mitral valve repair with the MitraClip system recently emerged as a viable and less invasive therapeutic option in patients with severe mitral regurgitation deemed to be high-risk surgical candidates. Mitral valve morphology and geometry
Autor:
Bruno Trimarco, Francesco Borgia, Vittorio Monda, Claudia Capozzolo, Giulio Bonzani, Anna Franzone, Orlando Piro, Giovanni Esposito, Ida Monterforte, Gennaro Galasso, Plinio Cirillo, Francesco Granata, Antonio Rapacciuolo, Attilio Varricchio, Eugenio Stabile, Elisabetta Moscarella
Publikováno v:
Cardiovascular Revascularization Medicine. 16:401-405
Background/purpose Coronary in-stent restenosis (ISR) is a clinical problem for which a satisfactory solution has not been found yet. Bioabsorbable drug eluting vascular scaffolds (BVSs) provide transient vessel scaffolding combined with prolonged dr
Autor:
Emanuele, Cigala, Ida, Monteforte, Orlando, Piro, Vittorio, Monda, Claudia, Capozzolo, Giulio, Bonzani
Publikováno v:
Giornale italiano di cardiologia (2006). 18(4)
Transcatheter aortic valve implantation (TAVI) is a validated technique for the treatment of aortic valve stenosis in patients with high surgical risk or inoperable. We present the case of an 80-year-old woman with severe aortic valve stenosis (mean
Autor:
Giulio Bonzani, Ciro Mauro, Rosario Farina, Bernardino Tuccillo, Alfredo Vetrano, Tonino Lanzillo, Paolo Calabrò, P. Tammaro, Plinio Cirillo, Paolo Capogrosso, Bruno Trimarco, Franco Mascia, Dario Formigli, Fortunato Scotto di Uccio, Orlando Piro, Giovanni Cimmino, Marino Scherillo, Renato Bianchi, Amelia Ravera, Alessandro Bellis
The incidence of ST-segment elevation myocardial infarction (STEMI) has significantly decreased. Conversely, the rate of non-STEMI (NSTEMI) has increased. Patients with NSTEMI have lower short-term mortality compared to patients with STEMI, whereas a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76536905849da0521dd030c07121289
http://hdl.handle.net/11588/655326
http://hdl.handle.net/11588/655326
Autor:
Orlando Piro, George J. Broze
Publikováno v:
Journal of Thrombosis and Haemostasis. 3:2677-2683
Summary. Background: Tissue factor pathway inhibitor (TFPI) is mainly produced by endothelial cells and alternative mRNA splicing generates two forms, TFPIα and TFPIβ. A portion of expressed TFPI remains associated with the cell surface through bot
Autor:
Michele D'Alto, Giovanni Battista Rossi, Raffaele Calabrò, Giuseppe Santoro, Roberto Muto, Maria Giovanna Russo, Carlo Pisacane, Orlando Piro
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 18(9)
A 41-year-old asymptomatic Italian male underwent cardiologic screening before blood donation. A transthoracic echocardiogram showed a huge right coronary artery (RCA) aneurysm continuing into a very twisted, worm-like channel, apparently draining in
Autor:
George J. Broze, Orlando Piro
Publikováno v:
Circulation. 110(23)
Background— Tissue factor pathway inhibitor (TFPI)-α, a key regulator of tissue factor–induced coagulation, contains 3 tandem Kunitz-type inhibitory domains. Kunitz-1 binds and inhibits factor VIIa in the factor VIIa/tissue factor complex, and K
Publikováno v:
Circulation. 108(5)
Background— The endothelium is a major source of tissue factor pathway inhibitor (TFPI), the endogenous regulator of TF-induced coagulation, and a significant proportion of the expressed TFPI remains associated with the endothelial surface. Methods
Background— Tissue factor pathway inhibitor (TFPI) is the endogenous inhibitor of the extrinsic coagulation pathway; however, its involvement during thrombus formation in patients with acute coronary syndromes (ACS) is still unknown. Methods and Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::484bee27dc46c66f8a123077272958e8
http://hdl.handle.net/11591/185480
http://hdl.handle.net/11591/185480
Autor:
Paolo Calabrò, Francesco Vigorito, Massimo Chiariello, Marta Ravera, Paola Tommasini, Orlando Piro, Mario De Felice, Davide D’Andrea, Nicola Corcione, Massimo Ragni, Annarita Gargiulo, Plinio Cirillo, Annamaria Rosica, Paolo Golino
Objective— Tissue factor (TF) is normally expressed at low levels in the media of blood vessels, but it is readily induced after vessel injury. It is not known whether vascular damage per se or thrombus formation is responsible for this phenomenon.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc601ec03e028758907823e7a85f6e2
http://hdl.handle.net/11591/184666
http://hdl.handle.net/11591/184666